Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 21.09.2026 MDEC.LN IE0007FIJUO5   50,002.00 USD   1,430,241.76   28.604  ...
-

UK Debt Management Office UK Regulatory Announcement: Issue of Debt

LONDON--(BUSINESS WIRE)--  DMO-TAS041/3731/002     The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk     A125\26 22 September 2026   PRESS NOTICE   RESULT OF THE SALE BY AUCTION OF £4750 MILLION OF 4⅝% TREASURY GILT 2032The United Kingdom Debt Management Office ("DMO") announces that the auction of £4,750 million of 4⅝% Treasury Gilt 2032 (ISIN Code: GB00BWGDRG14) has been allocated as follows:(Note: all prices in this notice are quoted in pounds and...
-

Object First Survey: 70% of IT Professionals Say AI-Powered Cyber Threats Increase Workplace Stress

DENVER--(BUSINESS WIRE)--Object First, the ransomware-proof on-premises backup storage company, today released findings from its second annual Under Pressure: Mental Health Challenges in IT & Security Roles survey, which reveals that 91% are uncomfortably stressed at work over IT security risks, an increase over 84% in 2025. The 1,100 IT and security professionals surveyed across the United States, United Kingdom, and Germany report mounting workplace pressure as threats become more sophist...
-

Blair Health Raises CAD $4.2M to Close the Specialist Gap in Women's Health

TORONTO--(BUSINESS WIRE)--Blair Health Raises CAD $4.2M to Close the Specialist Gap in Women's Health...
-

DataDome Report: Malicious Automated Traffic Is Growing 9x Faster Than Human Traffic — and Targeting Deeper Into the Customer Journey

NEW YORK--(BUSINESS WIRE)--DataDome, the leader in bot and agent trust management, today released The State of Bot & Agent Security Report, 2026 Edition, an analysis of more than one trillion requests across 75,000+ customer sites and a test of more than 20,000 popular websites. Malicious automated traffic grew more than nine times faster than human traffic between July 2025 and June 2026, with bad bot traffic increasing 124%. Scraping remained the leading threat, rising 185% year over year...
-

AI Adoption Surges Ahead of Governance Across the UK Public Sector

LONDON--(BUSINESS WIRE)--New research from SolarWinds, a leading provider of simple, powerful, secure observability and IT management software, reveals a gap between AI adoption and consistent governance in the UK public sector. While AI tools are being deployed at pace, many organisations have yet to establish the policies, oversight and visibility needed to manage them effectively. The report, titled Racing to Deploy: How Public Sector AI Adoption Is Moving Faster Than the Foundations Needed...
-

MTTI Awarded $3.17 Million NCI Grant to Advance ¹⁷⁷Lu-EBRGD Development for Non-Small Cell Lung Cancer

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), a clinical-stage radiopharmaceutical company, today announced that it has been awarded a $3.17 million, five-year National Cancer Institute (NCI) grant to advance the development of ¹⁷⁷Lu-EBRGD, an investigational radiopharmaceutical targeting integrin αvβ3, for non-small cell lung cancer (NSCLC). The award, under NIH grant R01CA299133, will support an integrated translational program encompassing preclinical res...
-

HARMONi-GI1, a Phase III Trial Featuring Ivonescimab Plus Chemotherapy Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer from China, to Be Showcased in Presidential Symposium at ESMO 2026

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that data from the Phase III HARMONi-GI1 trial, conducted in China and sponsored by Akeso, Inc., featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab, will be featured as part of the Presidential Symposium II at the European Society for Medical Oncology 2026 Congress (ESMO 2026) which takes place October 23–27, 2026, in Madrid, Spain. The presentation will take place on Sunday, O...
-

Blair Health obtient 4,24 millions de dollars canadiens en financement pour élargir l’accès des femmes aux soins spécialisés

TORONTO--(BUSINESS WIRE)--Blair Health, société d’infrastructure clinique qui permet aux professionnels de soins généralistes de fournir des soins selon des parcours conçus par des spécialistes, a levé 4,24 millions CAD en financement d’amorçage, marquant le premier tour institutionnel de l’entreprise et portant le total des capitaux levés à ce jour à 4,5 millions CAD. Le financement a été mené conjointement par le Thrive Venture Fund de la Banque de développement du Canada (BDC), Accelia Capit...
-

DediProg to Showcase UltraConduct™ Rubber Pin Socket for AI/HPC IC Testing at SEMICON West 2026

TAIPEI, Taiwan--(BUSINESS WIRE)--DediProg Technology Co., Ltd., a global provider of IC programming and test socket solutions, today announced that it will showcase its latest UltraConduct™ Rubber Pin Socket for advanced AI and HPC applications at SEMICON West 2026, October 13–15 at the Moscone Center in San Francisco, California. “We are proud to bring this new contact solution to the evolving AI/HPC market,” said Chong Tsao, CEO of DediProg. “As advanced IC packages continue to grow in size a...